239 related articles for article (PubMed ID: 23395167)
1. LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans.
Singh R; De Aguiar RB; Naik S; Mani S; Ostadsharif K; Wencker D; Sotoudeh M; Malekzadeh R; Sherwin RS; Mani A
Cell Metab; 2013 Feb; 17(2):197-209. PubMed ID: 23395167
[TBL] [Abstract][Full Text] [Related]
2. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure.
Liu W; Singh R; Choi CS; Lee HY; Keramati AR; Samuel VT; Lifton RP; Shulman GI; Mani A
J Biol Chem; 2012 Mar; 287(10):7213-23. PubMed ID: 22232553
[TBL] [Abstract][Full Text] [Related]
3. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue.
Go GW; Srivastava R; Hernandez-Ono A; Gang G; Smith SB; Booth CJ; Ginsberg HN; Mani A
Cell Metab; 2014 Feb; 19(2):209-20. PubMed ID: 24506864
[TBL] [Abstract][Full Text] [Related]
4. Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease.
Srivastava R; Zhang J; Go GW; Narayanan A; Nottoli TP; Mani A
Cell Rep; 2015 Oct; 13(4):746-759. PubMed ID: 26489464
[TBL] [Abstract][Full Text] [Related]
5. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
6. The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome.
Abou Ziki MD; Mani A
Nutr Res; 2019 Oct; 70():18-25. PubMed ID: 30049588
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt co-receptor low density lipoprotein receptor-related protein-5 (LRP5).
Palsgaard J; Emanuelli B; Winnay JN; Sumara G; Karsenty G; Kahn CR
J Biol Chem; 2012 Apr; 287(15):12016-26. PubMed ID: 22337886
[TBL] [Abstract][Full Text] [Related]
8. LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGR.
Xie XM; Cao QL; Sun YJ; Zhang J; Liu KL; Qin YF; Long WJ; Luo ZJ; Li XW; Liang XH; Yuan GD; Luo XP; Xuan XP
Curr Med Sci; 2023 Apr; 43(2):274-283. PubMed ID: 36913109
[TBL] [Abstract][Full Text] [Related]
9. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis.
Go GW
Nutrients; 2015 Jun; 7(6):4453-64. PubMed ID: 26046396
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling.
Reinke L; Lam AP; Flozak AS; Varga J; Gottardi CJ
Biochem Biophys Res Commun; 2016 Feb; 470(3):606-612. PubMed ID: 26797284
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a.
Wang S; Song K; Srivastava R; Dong C; Go GW; Li N; Iwakiri Y; Mani A
FASEB J; 2015 Aug; 29(8):3436-45. PubMed ID: 25917329
[TBL] [Abstract][Full Text] [Related]
12. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
Park DS; Seo JH; Hong M; Choi SC
Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
[TBL] [Abstract][Full Text] [Related]
13. The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway.
Xu Y; Chen D; Lin XX; Zhao Q; Guo J; Chen LJ; Zhang W; Xiao J; Lian GH; Peng SF; Guo D; Yang H; Obianom O; Shu Y; Chen Y
Arch Toxicol; 2019 Jun; 93(6):1679-1695. PubMed ID: 30976847
[TBL] [Abstract][Full Text] [Related]
14. The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis.
Ip W; Shao W; Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1166-76. PubMed ID: 22967502
[TBL] [Abstract][Full Text] [Related]
15. Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.
Brännmark C; Nyman E; Fagerholm S; Bergenholm L; Ekstrand EM; Cedersund G; Strålfors P
J Biol Chem; 2013 Apr; 288(14):9867-9880. PubMed ID: 23400783
[TBL] [Abstract][Full Text] [Related]
16. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.
Koslowski MJ; Teltschik Z; Beisner J; Schaeffeler E; Wang G; Kübler I; Gersemann M; Cooney R; Jewell D; Reinisch W; Vermeire S; Rutgeerts P; Schwab M; Stange EF; Wehkamp J
PLoS Genet; 2012; 8(2):e1002523. PubMed ID: 22393312
[TBL] [Abstract][Full Text] [Related]
17. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
[TBL] [Abstract][Full Text] [Related]
18. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein receptor-related protein 6 regulates alternative pre-mRNA splicing.
Yuan T; Wang S; Hu C; Wu Y; Liang D; Li L; Liu Y; Li J; Chen YH
J Cell Mol Med; 2018 Oct; 22(10):4653-4663. PubMed ID: 30070011
[TBL] [Abstract][Full Text] [Related]
20. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
